Photo from Daneng Li/X
Jun 16, 2024, 20:00
Daneng Li: SKYSCRAPER-14 a Phase III study on advanced hepatocellular carcinoma
Daneng Li, GI Medical Oncologist at City of Hope, shared on X/Twitter:
“Out now, the Methods Full article: IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma. 1st global study with Atezo/bev as comparator. Hopeful for patients with hepatocellular carcinoma.”
Source: Daneng Li/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 06:59
Oct 23, 2024, 05:24
Oct 23, 2024, 05:17
Oct 23, 2024, 05:11
Oct 23, 2024, 05:05
Oct 23, 2024, 04:41
Oct 23, 2024, 04:34
Oct 23, 2024, 04:16
Oct 23, 2024, 04:04